Alyeska Investment Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-68,406	Closed	-$871K	–	527
2014 Q3	$871K	Buy	+68,406	New	+$871K	0.02%	318
2014 Q2	–	Sell	-50,000	Closed	-$1.41M	–	431
2014 Q1	$1.41M	Buy	+50,000	New	+$1.41M	0.04%	232